Antinociception by neutrophil-derived opioid peptides in noninflamed tissue-Role of hypertonicity and the perineurium

Brain, Behavior, and Immunity

Volumn 23, Issue 4, 2009, Pages 548-557

  Rittner, H L ^a,b   Hackel, D ^a,b   Yamdeu, R S ^a   Mousa, S A ^a   Stein, C ^a   Schafer M ^a   Brack, A ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Analgesia; Formyl Met Leu Phe; Granulocyte; Hypertonic saline; p38 MAPK

Indexed keywords

AMINO ACID; BETA ENDORPHIN; CXCL2 CHEMOKINE; FORMYL METHIONYLLEUCYLPHENYLALANINE; MACROPHAGE INFLAMMATORY PROTEIN 2; METENKEPHALIN; MITOGEN ACTIVATED PROTEIN KINASE P38; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; INFLAMMATION; MALE; NEUTROPHIL; NONHUMAN; PAIN THRESHOLD; PERINEURIUM; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ANALGESIA; ANALGESICS, OPIOID; ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BETA-ENDORPHIN; BLOTTING, WESTERN; CELL COUNT; DRUG ADMINISTRATION SCHEDULE; ENKEPHALIN, METHIONINE; FLOW CYTOMETRY; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NECROSIS; NEUTROPHILS; OPIOID PEPTIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PAIN THRESHOLD; PERIPHERAL NERVES; PHOSPHORYLATION; PYRIDINES; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; SALINE SOLUTION, HYPERTONIC;

EID: 63249106007     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2009.02.007     Document Type: Article

References (33)

1. Alessandri-Haber N., Joseph E., Dina O.A., Liedtke W., and Levine J.D. TRPV4 mediates pain-related behavior induced by mild hypertonic stimuli in the presence of inflammatory mediator. Pain 118 (2005) 70-79
2. Antonijevic I., Mousa S.A., Schäfer M., and Stein C. Perineurial defect and peripheral opioid analgesia in inflammation. J. Neurosci. 15 (1995) 165-172
3. Bennett R. Myofascial pain syndromes and their evaluation. Best Pract. Res. Clin. Rheumatol. 21 (2007) 427-445
4. Borregaard N., and Cowland J.B. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89 (1997) 3503-3521
5. Brack A., Labuz D., Schlitz A., Rittner H.L., Machelska H., Schäfer M., Rezka R., and Stein C. Tissue monocytes/macrophages in inflammation: hyperalgesia versus opioid-mediated peripheral antinociception. Anesthesiology 101 (2004) 204-211
6. Brack A., Rittner H.L., Machelska H., Leder K., Mousa S.A., Schäfer M., and Stein C. Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells. Pain 112 (2004) 229-238
7. Brack A., Rittner H.L., Machelska H., Shaqura M., Mousa S.A., Labuz D., Zöllner C., Schäfer M., and Stein C. Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression. Pain 108 (2004) 67-75
8. Cerchiaro G.A., Scavone C., Texeira S., and Sannomiya P. Inducible nitric oxide synthase in rat neutrophils: role of insulin. Biochem. Pharmacol. 62 (2001) 357-362
9. Ciesla D.J., Moore E.E., Biffl W.L., Gonzalez R.J., and Silliman C.C. Hypertonic saline attenuation of the neutrophil cytotoxic response is reversed upon restoration of normotonicity and reestablished by repeated hypertonic challenge. Surgery 129 (2001) 567-575
10. Ciesla D.J., Moore E.E., Gonzalez R.J., Biffl W.L., and Silliman C.C. Hypertonic saline inhibits neutrophil (PMN) priming via attenuation of p38 MAPK signaling. Shock 14 (2000) 265-269
11. Ciesla D.J., Moore E.E., Zallen G., Biffl W.L., Silliman C.C., Junger W.G., Hoyt D.B., Davis R.E., Herdon-Remelius C., Namiki S., Junger H., Loomis W., and Altman A. Hypertonic saline attenuation of polymorphonuclear neutrophil cytotoxicity: timing is everything. J. Trauma 48 (2000) 388-395
12. Cuenda A., Rouse J., Doza Y.N., Meier R., Cohen P., Gallagher T.F., Young P.R., and Lee J.C. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364 (1995) 229-233
13. Cuschieri J., Gourlay D., Garcia I., Jelacic S., and Maier R.V. Hypertonic preconditioning inhibits macrophage responsiveness to endotoxin. J. Immunol. 168 (2002) 1389-1396
14. Davies S.P., Reddy H., Caivano M., and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351 (2000) 95-105
15. Dobrogowska D.H., and Vorbrodt A.W. Immunogold localization of tight junctional proteins in normal and osmotically-affected rat blood-brain barrier. J. Mol. Histol. 35 (2004) 529-539
16. Fahrner S.L., Shackford S.R., Bourguignon P., Bednar M., and Shatney-Leach L. Effect of medium tonicity and dextran on neutrophil function in vitro. J. Trauma 52 (2002) 285-292
17. Junger W.G., Hoyt D.B., Davis R.E., Herdon-Remelius C., Namiki S., Junger H., Loomis W., and Altman A. Hypertonicity regulates the function of human neutrophils by modulating chemoattractant receptor signaling and activating mitogen-activated protein kinase p38. J. Clin. Invest. 101 (1998) 2768-2779
18. Likar R., Koppert W., Blatnig H., Chiari F., Sittl R., Stein C., and Schäfer M. Efficacy of peripheral morphine analgesia in inflamed, non-inflamed and perineural tissue of dental surgery patients. J. Pain Symptom Manage 21 (2001) 330-337
19. Mocsai A., Jakus Z., Vantus T., Berton G., Lowell C.A., and Ligeti E. Kinase pathways in chemoattractant-induced degranulation of neutrophils: the role of p38 mitogen-activated protein kinase activated by Src family kinases. J. Immunol. 164 (2000) 4321-4331
20. Planas M.E., Rodriguez L., Sanchez S., Pol O., and Puig M.M. Pharmacological evidence for the involvement of the endogenous opioid system in the response to local inflammation in the rat paw. Pain 60 (1995) 67-71
21. Rittner H.L., and Brack A. Leukocytes as mediators of pain and analgesia. Curr. Rheumatol. Rep. 9 (2007) 503-510
22. Rittner H.L., Brack A., Machelska H., Mousa S.A., Bauer M., Schäfer M., and Stein C. Opioid peptide expressing leukocytes-identification, recruitment and simultaneously increasing inhibition of inflammatory pain. Anesthesiology 95 (2001) 500-508
23. Rittner, H.L., Hackel, D., Voigt, P., Mousa, S., Stolz, A., Labuz, D., Schäfer, M., Schaefer, M., Stein, C., Brack, A., 2009. Mycobacteria attenuate nociceptive responses by formyl peptide receptor triggered opioid peptide release from neutrophils. PLoS, Pathog. in press.
24. Rittner H.L., Labuz D., Richter J.F., Brack A., Schäfer M., Stein C., and Mousa S.A. CXCR1/2 ligands induce p38 MAPK-dependent translocation and release of opioid peptides from primary granules in vitro and in vivo. Brain Behav. Immun. 21 (2007) 1021-1032
25. Rittner H.L., Labuz D., Schaefer M., Mousa S.A., Schulz S., Schäfer M., Stein C., and Brack A. Pain control by CXCR2 ligands through Ca2+-regulated release of opioid peptides from polymorphonuclear cells. FASEB J. 20 (2006) 2627-2629
26. Rittner H.L., Mousa S.A., Labuz D., Beschmann K., Schäfer M., Stein C., and Brack A. Selective local PMN recruitment by CXCL1 or CXCL2/3 injection does not cause inflammatory pain. J. Leukoc. Biol. 79 (2006) 1022-1032
27. Stanton K., Alam H.B., Rhee P., Llorente O., Kirkpatrick J., and Koustova E. Human polymorphonuclear cell death after exposure to resuscitation fluids in vitro: apoptosis versus necrosis. J. Trauma 54 (2003) 1065-1074
28. Stein C., Gramsch C., and Herz A. Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin. J. Neurosci. 10 (1990) 1292-1298
29. Stein C., Hassan A.H., Przewlocki R., Gramsch C., Peter K., and Herz A. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc. Natl. Acad. Sci. USA 87 (1990) 5935-5939
30. Stein C., Schäfer M., and Machelska H. Attacking pain at its source: new perspectives on opioids. Nat. Med 9 (2003) 1003-1008
31. Vindrola O., Padros M.R., Sterin-Prync A., Ase A., Finkielman S., and Nahmod V. Proenkephalin system in human polymorphonuclear cells. Production and release of a novel 1.0-kDa peptide derived from synenkephalin. J. Clin. Invest. 86 (1990) 531-537
32. Weerasuriya A., Rapoport S.I., and Taylor R.E. Modification of permeability of frog perineurium to [14C]-sucrose by stretch and hypertonicity. Brain Res. 173 (1979) 503-512
33. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16 (1983) 109-110